Jenburkt Pharmaceuticals Ltd vs Vilin Bio Med Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Jenburkt Pharmaceuticals Ltd is ₹ 1068 as of 04 May 10:00 . The P/E Ratio of Jenburkt Pharmaceuticals Ltd changed from 11.1 on March 2021 to 13.9 on March 2025 . This represents a CAGR of 4.60% over 5 yearsThe P/E Ratio of Vilin Bio Med Ltd changed from 158.3 on March 2024 to 127.5 on March 2025 . This represents a CAGR of -10.25% over 2 years The Market Cap of Jenburkt Pharmaceuticals Ltd changed from ₹ 182.84 crore on March 2021 to ₹ 446.49 crore on March 2025 . This represents a CAGR of 19.55% over 5 yearsThe Market Cap of Vilin Bio Med Ltd changed from ₹ 26.51 crore on March 2024 to ₹ 28.46 crore on March 2025 . This represents a CAGR of 3.61% over 2 years The revenue of Jenburkt Pharmaceuticals Ltd for the Dec '25 is ₹ 44.84 crore as compare to the Sep '25 revenue of ₹ 47.64 crore. This represent the decline of -5.88% The revenue of Vilin Bio Med Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Jenburkt Pharmaceuticals Ltd for the Dec '25 is ₹ 9.24 crore as compare to the Sep '25 ebitda of ₹ 15.18 crore. This represent the decline of -39.13% The ebitda of Vilin Bio Med Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Jenburkt Pharmaceuticals Ltd changed from ₹ 7.42 crore to ₹ 5.93 crore over 7 quarters. This represents a CAGR of -12.02% The net profit of Vilin Bio Med Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Jenburkt Pharmaceuticals Ltd changed from 28.37 % on March 2021 to 24.76 % on March 2025 . This represents a CAGR of -2.69% over 5 yearsThe Dividend Payout of Vilin Bio Med Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Jenburkt Pharmaceuticals Ltd

Jenburkt Pharmaceuticals Limited, incorporated in 1985, was formed a joint venture to diversify into the healthcare and pharmaceutical industry, by Bhuta family.
The Company is engaged in manufacturing and marketing of speciality and high quality pharmaceutical formulations and healthcare products. Presently, the Company manufactures and markets pharmaceutical formulations in India and internationally across 13 countries.
It has more than 1,000 stockists and their reach extends to 400,000+ pharmacies across the globe.
The organisation caters to government, semi-government institutions, missionary hospitals, public sector enterprises, etc. Apart from this. the Company operate manufacturing plant at Sihor-Gujarat, approved as per W.H.O (World Health Organisation) guidelines with current Good Manufacturing Practices (GMP) requirements.

About Vilin Bio Med Ltd

Vilin Bio Med Limited was originally incorporated on June 29, 2005, which commenced business on July 11, 2005 issued by Registrar of Companies, Andhra Pradesh, Hyderabad.
The Company started its first commercial production in 2006.
In 2007, the Company expanded the Phase 2 for Beta Lactum facility with 16000 sft for Tablet, Capsule and Dry Syrup sections.
In 2010, it acquired more than 1000 molecules Drug Approvals with different strengths in therapeutics of Diabetic, Neuro and Cardio. The Company added the Sachet section in Non-Beta Lactum facility in 2014.
The Company allotted a fresh issue of 40,00,000 Equity Shares of Rs 10/- each by its Initial Public Offering by raising funds aggregating to Rs 12 Crore on June 7, 2023. At present, Company is engaged in domestic business of manufacturing Pharmaceuticals products and the Manufacturing Unit is located in Roorkee, in the State of Uttarakhand.

FAQs for the comparison of Jenburkt Pharmaceuticals Ltd and Vilin Bio Med Ltd

Which company has a larger market capitalization, Jenburkt Pharmaceuticals Ltd or Vilin Bio Med Ltd?

Market cap of Jenburkt Pharmaceuticals Ltd is 460 Cr while Market cap of Vilin Bio Med Ltd is 59 Cr

What are the key factors driving the stock performance of Jenburkt Pharmaceuticals Ltd and Vilin Bio Med Ltd?

The stock performance of Jenburkt Pharmaceuticals Ltd and Vilin Bio Med Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Jenburkt Pharmaceuticals Ltd and Vilin Bio Med Ltd?

As of May 4, 2026, the Jenburkt Pharmaceuticals Ltd stock price is INR ₹1044.25. On the other hand, Vilin Bio Med Ltd stock price is INR ₹38.85.

How do dividend payouts of Jenburkt Pharmaceuticals Ltd and Vilin Bio Med Ltd compare?

To compare the dividend payouts of Jenburkt Pharmaceuticals Ltd and Vilin Bio Med Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.